MeSH tree: E05.290
A KAIST research team has developed a highly stretchable microelectrode array (sMEA) designed for non-invasive electrophysiological signal measurement of organoids. The team was led by Professor Hyunjoo J. Lee from the School ...
Jan 14, 2025
0
0
A picture may be worth a thousand words, but they both have a lot of work to do to catch up to BiomedGPT. A Lehigh University research team has now collaborated with Massachusetts General Hospital in an effort to transform ...
Nov 4, 2024
0
21
New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies ...
Jul 26, 2024
0
0
Researchers from Bar-Ilan University, in collaboration with Sheba Medical Center, have developed a novel platform to model human muscle diseases in the C. elegans worm. This innovation facilitates the study of diseases in ...
May 15, 2024
0
20
Searching for evidence for health technology assessments (HTAs) is time-consuming because the evidence identified must be a reliable basis for robust assessment results: The scientific knowledge about the benefits and harms ...
Apr 17, 2024
0
0
A study published in Health Data Science introduces an end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field of drug discovery. This innovative framework ...
Mar 29, 2024
0
1
A new editorial paper titled "The fate of drug discovery in academia; dumping in the publication landfill?" has been published in Oncotarget.
Feb 5, 2024
0
0
Generative artificial intelligence could transform health care through things like drug development and quicker diagnoses, but the World Health Organization warned Thursday of the potential pitfalls in rushing to embrace ...
Jan 18, 2024
0
0
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel "genetic priority score" (GPS) that will integrate various types ...
Jan 3, 2024
0
54
